| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.44 | 0.009 | 0.447 | Sodium/bile acid cotransporter inhibitor | 0.426 0.011 CID_71549171 0.447 0.008 CID_10393637 | CID_10393637 | |
| 0.42 | 0.052 | 0.42 | Toll-Like receptor 7 agonist | 0.23 0.167 CID_71549171 0.416 0.054 CID_10393637 | ||
| 0.413 | 0.055 | 0.413 | Toll-Like receptor agonist | 0.222 0.177 CID_71549171 0.409 0.057 CID_10393637 | ||
| 0.231 | 0.005 | 0.231 | Leukotriene antagonist | 0.148 0.01 CID_71549171 0.217 0.005 CID_10393637 | ||
| 0.345 | 0.142 | 0.406 | Apoptosis agonist | 0.406 0.111 CID_71549171 0.393 0.117 CID_10393637 | CID_71549171 | |
| 0.176 | 0.004 | 0.176 | Bcl2 antagonist | 0.152 0.005 CID_71549171 0.164 0.005 CID_10393637 | ||
| 0.15 | 0.005 | 0.15 | Leukotriene D4 antagonist | 0.111 0.005 CID_71549171 0.123 0.005 CID_10393637 | ||
| 0.275 | 0.18 | 0.279 | Calcium channel L-type activator | 0.279 0.175 CID_71549171 0.248 0.207 CID_10393637 | CID_71549171 | |
| 0.101 | 0.006 | 0.101 | Bcl-xL inhibitor | 0.085 0.009 CID_71549171 0.095 0.007 CID_10393637 | ||
| 0.169 | 0.074 | 0.169 | Mcl-1 antagonist | 0.131 0.111 CID_71549171 0.147 0.092 CID_10393637 | ||
| 0.109 | 0.031 | 0.109 | Bromodomain-containing protein 2 inhibitor | |||
| 0.085 | 0.018 | 0.09 | Prostaglandin E2 antagonist | 0.055 0.031 CID_71549171 0.09 0.017 CID_10393637 | CID_10393637 | |
| 0.106 | 0.054 | 0.106 | Platelet activating factor alpha antagonist | 0.081 0.079 CID_10393637 | ||
| 0.161 | 0.116 | 0.161 | Platelet aggregation inhibitor | 0.154 0.124 CID_10393637 | ||
| 0.206 | 0.162 | 0.232 | Angiogenesis inhibitor | 0.232 0.137 CID_71549171 0.205 0.163 CID_10393637 | CID_71549171 | |
| 0.07 | 0.028 | 0.07 | Kallikrein 7 inhibitor | 0.062 0.05 CID_71549171 0.065 0.04 CID_10393637 | ||
| 0.235 | 0.196 | 0.235 | Analgesic | |||
| 0.044 | 0.008 | 0.046 | HCV polyprotein inhibitor | 0.046 0.007 CID_71549171 0.041 0.011 CID_10393637 | CID_71549171 | |
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | |||
| 0.096 | 0.069 | 0.098 | Bronchodilator | 0.098 0.067 CID_10393637 | CID_10393637 | |
| 0.116 | 0.089 | 0.116 | Sodium channel (voltage-gated) blocker | |||
| 0.054 | 0.027 | 0.054 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 CID_10393637 | ||
| 0.128 | 0.104 | 0.128 | Phospholipase A2 inhibitor | |||
| 0.119 | 0.096 | 0.194 | Vascular endothelial growth factor 3 antagonist | 0.194 0.044 CID_71549171 | CID_71549171 | |
| 0.057 | 0.034 | 0.059 | Prostaglandin antagonist | 0.059 0.032 CID_10393637 | CID_10393637 | |
| 0.043 | 0.042 | 0.043 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.025 | 0.026 | 0.03 | Prostaglandin EP3 antagonist | 0.03 0.021 CID_10393637 | CID_10393637 | |
| 0.028 | 0.04 | 0.037 | Farnesoid X receptor agonist | 0.037 0.027 CID_10393637 | CID_10393637 | |
| 0.013 | 0.025 | 0.014 | CC chemokine 10 receptor antagonist | 0.014 0.013 CID_71549171 | CID_71549171 | |
| 0.05 | 0.068 | 0.091 | Prostaglandin F2 alpha antagonist | 0.091 0.015 CID_10393637 | CID_10393637 | |
| 0.039 | 0.071 | 0.058 | Elastase inhibitor | 0.058 0.032 CID_71549171 | CID_71549171 | |
| 0.013 | 0.054 | 0.022 | CYP24 inhibitor | 0.022 0.017 CID_10393637 | CID_10393637 | |
| 0.081 | 0.132 | 0.127 | Bone formation stimulant | 0.127 0.079 CID_10393637 | CID_10393637 | |
| 0.066 | 0.156 | 0.132 | Tubulin antagonist | 0.132 0.07 CID_71549171 | CID_71549171 | |
| 0.194 | 0.284 | 0.269 | Cyclophilin D inhibitor | 0.269 0.192 CID_10393637 | CID_10393637 | |
| 0.01 | 0.18 | 0.061 | Beta tubulin antagonist | 0.061 0.039 CID_71549171 | CID_71549171 | |
| 0.062 | 0.304 | 0.16 | Antimitotic | 0.16 0.112 CID_71549171 | CID_71549171 | |
| 0.099 | 0.432 | 0.175 | Peptidyltransferase inhibitor | 0.175 0.138 CID_10393637 | CID_10393637 | |
| 0.053 | 0.403 | 0.101 | Interleukin 2 antagonist | 0.101 0.087 CID_71549171 | CID_71549171 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |